STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 61 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $196,000 | -1.5% | 15,263 | -27.2% | 0.00% | – |
| Q4 2018 | $199,000 | -91.2% | 20,968 | -84.7% | 0.00% | -100.0% |
| Q3 2018 | $2,268,000 | +600.0% | 136,611 | +576.4% | 0.00% | – |
| Q2 2018 | $324,000 | -73.4% | 20,198 | -74.6% | 0.00% | – |
| Q1 2018 | $1,216,000 | -32.8% | 79,493 | -53.0% | 0.00% | -100.0% |
| Q4 2016 | $1,809,000 | +36.4% | 169,058 | +38.1% | 0.00% | – |
| Q3 2016 | $1,326,000 | +60.0% | 122,422 | -0.1% | 0.00% | – |
| Q2 2016 | $829,000 | +41.0% | 122,497 | -3.0% | 0.00% | – |
| Q1 2016 | $588,000 | -27.9% | 126,227 | -2.4% | 0.00% | – |
| Q4 2015 | $816,000 | -30.7% | 129,374 | -2.9% | 0.00% | – |
| Q3 2015 | $1,177,000 | -23.3% | 133,221 | +2.2% | 0.00% | -100.0% |
| Q2 2015 | $1,535,000 | -19.8% | 130,393 | -1.4% | 0.00% | 0.0% |
| Q1 2015 | $1,913,000 | -13.0% | 132,205 | +2.6% | 0.00% | 0.0% |
| Q4 2014 | $2,199,000 | +125.8% | 128,896 | +64.9% | 0.00% | – |
| Q3 2014 | $974,000 | -25.0% | 78,151 | -11.7% | 0.00% | -100.0% |
| Q2 2014 | $1,298,000 | -20.3% | 88,467 | +10.6% | 0.00% | 0.0% |
| Q1 2014 | $1,629,000 | +99.1% | 79,996 | +91.7% | 0.00% | – |
| Q4 2013 | $818,000 | -48.0% | 41,734 | +20.2% | 0.00% | -100.0% |
| Q3 2013 | $1,573,000 | – | 34,718 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|